Welcome to our dedicated page for Hamilton Insurance Group SEC filings (Ticker: HG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hamilton Insurance Group, Ltd. (NYSE: HG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its specialty insurance and reinsurance operations. As a Bermuda-incorporated direct property and casualty insurance carrier with International and Bermuda segments, Hamilton uses SEC reports to explain its underwriting performance, investment results, capital management and key corporate events.
On this page, you can review Hamilton’s current reports on Form 8-K, which disclose material events such as quarterly financial results, increases to the company’s share repurchase authorization, amendments to letter of credit and reimbursement facilities, and senior leadership appointments. These filings often include or reference press releases, supplementary financial information and investor presentations that expand on segment performance, combined ratios, attritional and catastrophe loss ratios, and net investment income.
Hamilton’s periodic filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q (when available in the broader SEC record), typically provide more comprehensive discussions of its International and Bermuda segments, underwriting platforms—Hamilton Global Specialty, Hamilton Select and Hamilton Re—and risk factors, as well as details on capital structure and book value per common share. For investors interested in governance and compensation, Hamilton’s proxy materials and related disclosures offer additional context.
Stock Titan enhances access to these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly understand changes in underwriting results, catastrophe loss experience, capital management actions and financing arrangements such as Funds at Lloyd’s letter of credit facilities. Real-time updates from EDGAR mean new Hamilton filings, including Form 4 insider transaction reports when filed, appear promptly, allowing investors and analysts to monitor regulatory disclosures for HG in one place.
Megan Jane Graves, listed as an officer (CEO, Hamilton Re) and director of Hamilton Insurance Group, Ltd. (HG), reported a sale of Class B common shares. The filing shows a total disposition of 50,000 Class B shares executed on 08/13/2025 at a weighted-average price of $23.7468 per share. After this transaction, the reporting person beneficially owned 104,674 Class B shares, held directly. The form includes a footnote stating the sale occurred in multiple transactions at prices ranging from $23.50 to $24.04 and offers to provide a breakdown of quantities by price on request.
Hamilton Insurance Group, Ltd. (HG) reporting person Megan Jane Graves, CEO of Hamilton Re, sold 50,000 Class B common shares on 08/12/2025 at a weighted average price of $23.2739 per share. After the sale the reporting person beneficially owned 154,674 Class B common shares. The filing notes the sale occurred in multiple transactions at prices ranging from $23.02 to $23.53 and that detailed allocation by price is available on request. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
This Form 144 notice reports a proposed Rule 144 sale of 6,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $139,860 and an approximate sale date of 08/13/2025. The shares are part of an outstanding share base of 65,606,760 shares and were acquired as Restricted Stock Units on 01/01/2023. The filing shows no sales in the past three months for the reporting person and includes the broker's address. Several standard filer and issuer identification fields (such as filer CIK and issuer name/contact details) are not populated in the provided content.
Hamilton Insurance Group, Ltd. notice reports a proposed sale of 100,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,331,000 and an approximate sale date of 08/12/2025. The issuer has 65,606,760 shares outstanding. The 100,000 shares were acquired as restricted stock vesting under a registered plan on multiple dates in 2024–2025, with the individual vesting lots listed in the notice and totaling 100,000 shares. Separately, Megan Jane Graves sold 25,000 shares on 05/16/2025 for gross proceeds of $525,500. The filer represents there is no undisclosed material adverse information.